Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of lung MRI in lung cancer screening.

European radiology·2019
Same author

Feasibility study of ultrasonic elliptical vibration-assisted reaming of carbon fiber reinforced plastics/titanium alloy stacks.

Ultrasonics·2016
Same author

High-performance SERS substrate based on hybrid structure of graphene oxide/AgNPs/Cu film@pyramid Si.

Scientific reports·2016
Same author

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.

Nature·2016
Same author

The Effects of Dietary Macronutrient Balance on Skin Structure in Aging Male and Female Mice.

PloS one·2016
Same author

Associations of proteins relevant to MAPK signaling pathway (p38MAPK-1,HIF-1 and HO-1) with coronary lesion characteristics and prognosis of peri-menopausal women.

Lipids in health and disease·2016
Same journal

Flexible Survival Extrapolation with Blended Hazards: Accounting for Treatment Effect Waning in Health Technology Assessment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes-Chronic Kidney Disease Model.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Cardiovascular Risk Estimation and Statin Adherence: A Historical Cohort Study.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Taste or Scale? Methodological Approach to Health Preferences Comparison across Groups.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Mind the Gap: Impact of New Labels on Public Perceptions and Calculated Risk of Adverse Outcomes after a Melanoma In Situ Diagnosis-A Secondary Analysis of an Online Randomized Experiment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Metamodel-Based General-Purpose Autocalibration Tool for Simulation Models.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Cohort decomposition for Markov cost-effectiveness models.

Gordon Hazen1, Zhe Li1

  • 1Department of Industrial Engineering and Management Sciences, Northwestern University, Evanston, Illinois.

Medical Decision Making : an International Journal of the Society for Medical Decision Making
|June 10, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces a method to simplify complex Markov models used in cost-effectiveness analysis. By decomposing cohort analysis into independent single-factor analyses, researchers can achieve more efficient and transparent modeling of health outcomes and costs.

Related Experiment Videos

Last Updated: Jun 12, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Health economics
  • Mathematical modeling
  • Biostatistics

Background:

  • Markov models are standard for cost-effectiveness analysis, calculating costs and quality-adjusted life years (QALYs).
  • These models often comprise multiple simple factors, where health states are vectors of these factors.
  • Current methods may not fully leverage the structure of multi-component health states.

Purpose of the Study:

  • To present a method for decomposing standard cohort analysis in Markov models.
  • To demonstrate how to combine results from independent single-factor analyses.
  • To enhance the transparency and efficiency of cost-effectiveness modeling.

Main Methods:

  • Developed formulas for cohort decomposition in discrete time for models without probabilistic dependence between factors.
  • Illustrated the method using published cost-effectiveness analyses.
  • Explored graphical representation of model components.

Main Results:

  • Standard cohort analysis can be decomposed into independent single-factor analyses when factors are probabilistically independent.
  • This decomposition simplifies calculations and improves computational efficiency.
  • Graphical depiction of factors enhances model transparency and facilitates critique.

Conclusions:

  • The proposed cohort decomposition method offers a simpler and more computationally efficient approach to Markov modeling in cost-effectiveness analysis.
  • Explicitly identifying and visualizing model factors improves model clarity and peer review.
  • This approach is particularly beneficial for models with multi-component health states and no assumed probabilistic dependence.